GFAP and Alzheimer disease: Other biomarkers, which are non-specific, but highly associated with disease progression biomarkers, such as neurofibrillary light chain (NfL) [16] and glial fibrillary acidic protein (GFAP) [17], have also been shown to contribute to AD diagnosis.